Type to search

Aristea Therapeutics Announces Dosing of First Patient in Phase 2b Trial of RIST4721 in Palmoplantar Pustulosis | Pharmtech Focus
Aristea Therapeutics Announces Key Leadership Appointments to Advance its Clinical Pipeline | Pharmtech Focus
Aristea Appoints Justin Thacker as Chief Financial Officer | Pharmtech Focus